UnitedHealth Group Incorporated…

Wall Street analysts predict that UnitedHealth Group Incorporated (NYSE:UNH) will report sales of $78.55 billion for the current fiscal quarter, according to Zacks. Nine analysts have provided estimates for UnitedHealth Group’s earnings, with estimates ranging from $77.73 billion to $79.09 billion. UnitedHealth Group reported sales of $70.20 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 11.9%. The company is scheduled to issue its next earnings report on Thursday, April 21st.

According to Zacks, analysts expect that UnitedHealth Group will report full year sales of $319.12 billion for the current fiscal year, with estimates ranging from $315.91 billion to $320.72 billion. For the next financial year, analysts expect that the company will post sales of $345.27 billion, with estimates ranging from $339.53 billion to $353.87 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, January 19th. The healthcare conglomerate reported $4.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $4.30 by $0.18. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The firm had revenue of $73.74 billion during the quarter, compared to analysts’ expectations of $72.86 billion. During the same period in the prior year, the company posted $2.52 EPS. The company’s revenue was up 12.6% on a year-over-year basis.


There aren’t many days left on the calendar… and yet the global semiconductor market grew to $466.2 billion – in spite of the pandemic.

Better still, the chip shortage has created huge opportunities for recurring success.

These four tech companies are well-positioned to take advantage of this rapidly growing demand.

UNH has been the topic of a number of analyst reports. Royal Bank of Canada upped their price objective on shares of UnitedHealth Group from $476.00 to $512.00 and gave the company an “outperform” rating in a research note on Wednesday, December 1st. UBS Group increased their target price on shares of UnitedHealth Group from $435.00 to $452.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 1st. They noted that the move was a valuation call. Morgan Stanley increased their target price on shares of UnitedHealth Group from $499.00 to $526.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 1st. Edward Jones assumed coverage on shares of UnitedHealth Group in a report on Monday, January 10th. They set a “buy” rating on the stock. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 target price for the company in a report on Wednesday, October 27th. Two equities research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $499.04.

NYSE:UNH opened at $461.17 on Friday. The firm’s fifty day moving average is $470.37 and its 200-day moving average is $438.42. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.77 and a current ratio of 0.77. UnitedHealth Group has a 52 week low of $320.35 and a 52 week high of $509.23. The firm has a market cap of $434.35 billion, a P/E ratio of 28.61, a P/E/G ratio of 1.49 and a beta of 0.86.

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 14th. Investors of record on Monday, December 6th were issued a dividend of $1.45 per share. The ex-dividend date was Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a yield of 1.26%. UnitedHealth Group’s dividend payout ratio is currently 35.98%.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total transaction of $1,111,750.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. Corporate insiders own 0.55% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the company. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the 2nd quarter valued at about $26,000. Activest Wealth Management purchased a new stake in UnitedHealth Group during the 2nd quarter valued at about $29,000. Tompkins Financial Corp purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $32,000. Annapolis Financial Services LLC grew its position in UnitedHealth Group by 57.9% during the 3rd quarter. Annapolis Financial Services LLC now owns 90 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 33 shares during the last quarter. Finally, Level Financial Advisors Inc. bought a new position in UnitedHealth Group during the 4th quarter valued at about $45,000. 86.10% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Read More: What are Bollinger Bands?

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in UnitedHealth Group right now?

Before you consider UnitedHealth Group, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and UnitedHealth Group wasn’t on the list.

While UnitedHealth Group currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here


Hippo Sighting Report

Help us out, we really appreciate it.

Help contribute to our research, and let us know if you have seen similar situations that we may have missed. Our team will review the details you provide and add to our main list once we verify the information.

stay informed

Subscribe and get the updated Hippo List.

Get notified when we release our updated lists by email.

Make a Donation

Thank you for subscribing!

We will send you an email to confirm your details.  Welcome aboard!

Thanks for sending us your report.

We will review your information, and publish in on our list once we validate the details.